olivier barbier
Laval University
Quebec, Canada
Associate Editor
Gastrointestinal and Hepatic Pharmacology
Laval University
Quebec, Canada
Associate Editor
Gastrointestinal and Hepatic Pharmacology
University of Genoa
Genoa, Italy
Associate Editor
Pharmacology of Anti-Cancer Drugs
Institute for Cancer Research and Treatment (IRCC)
Candiolo, Italy
Associate Editor
Pharmacology of Anti-Cancer Drugs
Tel Aviv University
Tel Aviv, Israel
Associate Editor
ELSI in Science and Genetics
Downstate Health Sciences University
Brooklyn, United States
Associate Editor
Cardiovascular and Smooth Muscle Pharmacology
University of British Columbia
Vancouver, Canada
Associate Editor
Neuropharmacology
University of Miami
Coral Gables, United States
Associate Editor
Pharmacology of Ion Channels and Channelopathies
INSERM U1087 Institut du Thorax
Nantes, France
Associate Editor
Pharmacology of Ion Channels and Channelopathies
Florida Institute of Technology
Melbourne, United States
Associate Editor
Integrative and Regenerative Pharmacology
Segal Cancer Centre
Montreal, Canada
Associate Editor
Pharmacology of Anti-Cancer Drugs
University of Applied Sciences Emden Leer
Emden, Germany
Associate Editor
Predictive Toxicology
University of Graz
Graz, Austria
Associate Editor
Ethnopharmacology
Virginia Commonwealth University, Dept. of Physiology & Biophysics
Richmond, VA, United States
Associate Editor
Pharmacology of Ion Channels and Channelopathies
Central Institute of Medicinal and Aromatic Plants, Council of Scientific and Industrial Research (CSIR)
Lucknow, India
Associate Editor
Ethnopharmacology
Theravance Biopharma
South San Francisco, United States
Associate Editor
Gastrointestinal and Hepatic Pharmacology
Université Paris Cité
Paris, France
Associate Editor
Drug Metabolism and Transport